Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease

Nephrology Dialysis Transplantation

Volumn 22, Issue 11, 2007, Pages 3298-3303

  Betjes, Michiel G H ^a   Litjens, Nicolle H R ^a   Zietse, Robert ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerotic disease; C reactive protein; Cytomegalovirus; End stage renal disease

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HYPERTENSION; INDEPENDENT VARIABLE; INFLAMMATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CYTOMEGALOVIRUS INFECTIONS; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; ODDS RATIO; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SMOKING;

EID: 36749004391     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm348     Document Type: Article

References (20)

1. Shlipak MG, Fried LF, Cushman M et al. Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors. JAMA 2005; 293: 1737-1745
2. Pecoits-Filho R, Heimburger O, Barany P et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003; 41: 1212-1218
3. Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and non-traditional risk factors predict coronary heart disease in chronic kidney disease: Results from the atherosclerosis risk in communities study (ARIC). J Am Soc Nephrol 2005; 16: 529-538
4. Smeeth L, Thomas DS, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351: 2611-2618
5. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874
6. Stassen FR, Vega-Córdova X, Vliegen I, Bruggeman CA. Immune activation following cytomegalovirus infection: More important than direct viral effects in cardiovascular disease? J Clin Virol 2006; 35: 349-353
7. Muhlestein JB, Anderson JL. Infectious serology and atherosclerosis. How burdensome is the risk? Circulation 2003; 107: 220-222
8. Zhu J, Quyyumi AA, Norman JE, Csako G, Epstein SE. Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 1999; 34: 1738-1743
9. Muhlestein JB, Horne BD, Carlquist JF et al. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 2000; 102: 1917-1923
10. Blankenberg S, Rupprecht HJ, Bickel C et al. Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation 2001; 103: 2915-2921
11. Falagas ME, Griffiths J, Prekezes J, Worthington M. Cytomegalovirus colitis mimicking colon carcinoma in an HIV-negative patient with chronic renal failure. Am J Gastroenterol 1996; 91: 168-169
12. Quintana LF, Collada S, Coll E, Lopez-Pedret J, Cases A. Cytomegalovirus esophagitis in a patient on peritoneal dyalisis. Nefrologia 2005; 25: 201-204
13. Verkade MA, van de Wetering J, Klepper M, Vaessen LMB, Weimar W, Betjes MGH. GM-CSF reduces the number of circulating dendritic cells in hemodialysis patients while enhancing the efficacy of hepatitis B vaccination. Kidney Int 2004; 66: 614-621
14. Litjens NHR, van Druningen CJ, Betjes MGH. Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes. Clin Immunol 2006; 118: 83-91
15. Wolf SC, Brehm BR, Mayer O, Jurgens S, Schultze G, Risler T. Infectious risk factors for atherosclerotic vascular disease in hemodialysis patients-Chlamydia pneumoniae but not Helicobacter pylori or cytomegalovirus is associated with increased C-reactive protein. Ren Fail 2004; 26: 279-287
16. + T Lymphocytes Depend on Infection with CMV. J Immunol 2003; 170: 4342-4348
17. van Leeuwen EM, Remmerswaal EB, Vossen MT et al. Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 2004; 173: 1834-1841
18. Liuzzo G, Goronzy JJ, Yang H et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 101: 2883
19. Sato K, Niessner A, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med 2006; 203: 239-250
20. Zhou YF, Shou M, Guetta E et al. Cytomegalovirus infection of rats increased the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation 1999; 100: 1569-1575